BRIEF published on 06/04/2024 at 07:35, 3 months 24 days ago Vallourec Showcases Technology Center and New Energy Solutions to Investors Technology R&D Hydrogen Storage Vallourec New Energies
PRESS RELEASE published on 06/04/2024 at 07:30, 3 months 25 days ago Vallourec Presents Its Leading Technology Center and New Energies Solutions to Investors Vallourec showcases its technology center and new energy solutions to investors, highlighting R&D, hydrogen storage innovation, and strategic targets for 2030 Investors R&D Technology Center Vallourec New Energies
BRIEF published on 06/03/2024 at 07:35, 3 months 25 days ago Vallourec: André Lacerda appointed Director of South America (Tubes Activities) South America Nomination Vallourec André Lacerda Tubes
PRESS RELEASE published on 06/03/2024 at 07:30, 3 months 26 days ago Vallourec: Andre Lacerda Appointed Senior Vice President of South America (Tubes Activities) Vallourec appoints Andre Lacerda as Senior Vice President of South America for Tubes segment, bringing extensive international experience and market knowledge South America Senior Vice President Vallourec André Lacerda Tubes
PRESS RELEASE published on 05/16/2024 at 07:30, 4 months 13 days ago Vallourec First Quarter 2024 Results
Published on 09/28/2024 at 02:06, 1 day 5 hours ago Global Education Communities Corp. Reports Second Tranche Closing of Non-Brokered Private Placement
Published on 09/28/2024 at 02:00, 1 day 5 hours ago bettermoo(d)’s Moodrink(TM) Featured in Banners of Well-Known Canadian Retailers
Published on 09/28/2024 at 00:10, 1 day 7 hours ago LQWD Technologies Announces Non-Brokered Private Placement Update
Published on 09/28/2024 at 14:01, 17 hours 28 minutes ago Turkiye Garanti Bankasi A.S.: Explanation on Subordinated Debt Securities to Qualified Investors
Published on 09/27/2024 at 22:30, 1 day 9 hours ago DREAM Pivotal Study Data Presented at the International Surgical Sleep Society 2024 Educational Update
Published on 09/27/2024 at 21:56, 1 day 9 hours ago EQS-Adhoc: FDA grants approval for Stelara® Biosimilar FYB202/OtulfiTM (ustekinumab-aauz)
Published on 09/27/2024 at 18:50, 1 day 12 hours ago PETROFAC ANNOUNCES IN-PRINCIPLE AGREEMENT ON FINANCIAL RESTRUCTURE
Published on 09/27/2024 at 18:40, 1 day 12 hours ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 09/27/2024 at 17:45, 1 day 13 hours ago NFL BIOSCIENCES: 2024 FIRST-HALF BUSINESS AND EARNINGS UPDATE
Published on 09/26/2024 at 18:00, 2 days 13 hours ago GUILLEMOT CORPORATION: Availability of the interim financial report to June 30, 2024
Published on 09/26/2024 at 18:00, 2 days 13 hours ago GUILLEMOT CORPORATION: 2024 CONSOLIDATED INTERIM RESULTS
Published on 09/26/2024 at 17:47, 2 days 13 hours ago imerys-26-September-2024-information-share-capital-and-voting-rights-as-of-31-August-2024